Literature DB >> 5798625

A platelet and granulocyte membrane defect in paroxysmal nocturnal hemoglobinuria: usefulness for the detection of platelet antibodies.

R H Aster, S E Enright.   

Abstract

The tendency of platelets and leukocytes to lyse after their interaction with antibody and complement was studied by measuring the release of (51)Cr from cells labeled with this isotope. Platelets from six patients with paroxysmal nocturnal hemoglobinuria (PNH) were 15-230 times more sensitive to antibodies and 10-32 times more sensitive to complement than normal platelets or platelets from patients with other types of thrombocytopenic or hemolytic disorders. Mixed white blood cell (WBC) preparations from patients with PNH were 3-20 times more sensitive to anti-WBC antibodies and 5-10 times more sensitive to C' than were WBC preparations from normal subjects, but PNH lymphocytes showed normal immunologic reactivity. PNH platelets, like PNH erythrocytes, lysed more readily than normal platelets in acidified serum and in media of reduced ionic strength, but these characteristics were not demonstrable with PNH WBC's under the conditions of study. In PNH, platelets appear to comprise a single population with respect to their sensitivity to immune lysis, yet their survival time as measured with (51)Cr falls within normal limits. PNH granulocytes likewise appear to consist of a single, uniformly sensitive population. It is concluded that, in PNH, platelets and granulocytes share the membrane defect characteristic of erythrocytes in this disorder. These observations support the concept that PNH arises as the result of a somatic mutation in a primitive cell capable of differentiating into erythroblast, myeloblast, and megakaryoblast lines. PNH platelets or enzymatically treated normal platelets permit the detection of some types of platelet antibodies in dilutions up to 2000-fold greater than is possible with currently available methods, a finding suggesting that the immune lysis technique will prove useful for the study of platelet immunology.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5798625      PMCID: PMC322341          DOI: 10.1172/JCI106084

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  SEPARATION OF LYMPHOCYTES, POLYMORPHONUCLEAR LEUKOCYTES AND MONOCYTES ON GLASS COLUMNS, INCLUDING TISSUE CULTURE OBSERVATIONS.

Authors:  Y RABINOWITZ
Journal:  Blood       Date:  1964-06       Impact factor: 22.113

2.  PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PRESENTING AS APLASTIC ANEMIA IN A CHILD. CASE REPORT WITH EVIDENCE OF DEFICIENT LEUKOCYTE ACETYLCHOLINESTERASE ACTIVITY.

Authors:  J D ROSS; E ROSENBAUM
Journal:  Am J Med       Date:  1964-07       Impact factor: 4.965

3.  PH OPTIMA IN IMMUNE HEMOLYSIS: A COMPARISON BETWEEN GUINEA PIG AND HUMAN COMPLEMENT.

Authors:  S YACHNIN; J M RUTHENBERG
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

Review 4.  PAROXYSMAL NOCTURNAL HEMOGLOBINURIA: CURRENT CONCEPTS OF CERTAIN PATHOPHYSIOLOGIC FEATURES.

Authors:  R C HARTMANN; D E JENKINS
Journal:  Blood       Date:  1965-05       Impact factor: 22.113

5.  Thrombin generation and clot retraction studies in paroxysmal nocturnal hemoglobinuria.

Authors:  J M FLEXNER; J V AUDITORE; R C HARTMANN
Journal:  Am J Clin Pathol       Date:  1960-01       Impact factor: 2.493

6.  Paroxysmal nocturnal hemoglobinuria; case study, including evidence of affection of the marrow in the disease.

Authors:  A M NUSSEY; D W DAWSON
Journal:  Blood       Date:  1956-08       Impact factor: 22.113

7.  Neutrophil (leucocyte) alkaline phosphatase in paroxysmal nocturnal haemoglobinuria.

Authors:  S M Lewis; J V Dacie
Journal:  Br J Haematol       Date:  1965-09       Impact factor: 6.998

8.  Immune lysis of normal human and paroxysmal nocturnal hemoglobinuria (PNH) red blood cells. I. The sensitivity of PNH red cells to lysis by complement and specific antibody.

Authors:  W F Rosse; J V Dacie
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

9.  Immune lysis of AET-treated normal red cells (PNH-like cells).

Authors:  G Sirchia; J V Dacie
Journal:  Nature       Date:  1967-08-12       Impact factor: 49.962

10.  Immunoreactions involving platelets. III. Quantitative aspects of platelet agglutination, inhibition of clot retraction, and other reactions caused by the antibody of quinidine purpura.

Authors:  N R SHULMAN
Journal:  J Exp Med       Date:  1958-05-01       Impact factor: 14.307

View more
  32 in total

1.  Complement-dependent and cell-dependent antiplatelet humoral antibody in sera from multi-transfused patients.

Authors:  J S Macdonald; J R Wunderlich; I Yust; R A Yankee
Journal:  Clin Exp Immunol       Date:  1975-08       Impact factor: 4.330

Review 2.  [Paroxysmal nocturnal hemoglobinuria].

Authors:  P Blaas; S Weber; G M Hänsch; H H Peter
Journal:  Klin Wochenschr       Date:  1990-03-05

3.  Disorders of the mononuclear phagocyte system. An analytical review.

Authors:  G Meuret
Journal:  Blut       Date:  1977-04

4.  Storage of reagent platelets for anti-platelet antibody testing in the 51Cr platelet lysis assay.

Authors:  G E Lizak; F C Grumet
Journal:  J Clin Pathol       Date:  1979-02       Impact factor: 3.411

5.  Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay accelerating factor.

Authors:  A Nicholson-Weller; J P March; S I Rosenfeld; K F Austen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-08       Impact factor: 11.205

6.  The assessment of drug-dependent and isoimmune antiplatelet antibodies by the use of platelet aggregometry.

Authors:  D Deykin; L J Hellerstein
Journal:  J Clin Invest       Date:  1972-12       Impact factor: 14.808

7.  Presence of the Tn antigen on hematopoietic progenitors from patients with the Tn syndrome.

Authors:  W Vainchenker; G Vinci; U Testa; A Henri; A Tabilio; M P Fache; H Rochant; J P Cartron
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Human platelet-initiated formation and uptake of the C5-9 complex of human complement.

Authors:  T S Zimmerman; W P Kolb
Journal:  J Clin Invest       Date:  1976-01       Impact factor: 14.808

9.  Paroxysmal nocturnal hemoglobinuria in an identical twin.

Authors:  H Freeman; J R Hill; A M Edwards; M W Wolowyk
Journal:  Can Med Assoc J       Date:  1973-11-17       Impact factor: 8.262

10.  Platelet membrane glycoprotein IIIa contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias.

Authors:  D S Beardsley; J E Spiegel; M M Jacobs; R I Handin; S E Lux
Journal:  J Clin Invest       Date:  1984-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.